Newsletter

November 18, 2006

Volume VII, Issue 92

Home Page : www.otcjournal.com
Email Questions or Comments To: editor@otcjournal.com

To OTC Journal Members:

Welcome To the New OTC Journal

This past week we launched an entirely new OTC Journal site, and I believe it will prove a far more valuable resource for microcap investors than the previous version.

Please take some time to visit the new site and explore. By now, you should know it is located at www.otcjournal.com. You will find it pleasantly user friendly. Information is far more accesible.I have modeled it after Yahoo! Finance, which I believe is the easiest stock related site to navigate and research information.

Working from left to right, here are some of the new features I believe you will find valuable:

The Left column: It starts with current price quotes of the major indexes. Moving down, you will find a list of the price targets and SSLs (suggested stop losses) for all the followed companies. Last, is a list of the followed companies. Just click on any name, and it will take you to a section for that company with far more comprehensive information than before. Moving down, there is a calendar for looking up past publications, followed by a series of links for one click RSS Feeds. You can use these RSS feeds if you want to imbed the OTC Journal content in your home page. For example, if you use a self designed Yahoo! home page, you can create a link to the most current OTC Journal edition and/or BLOG which will come up on your home page when you launch your browser.
The Middle Column: The very first section of the middle column is reserved for breaking events and timely information. I am planning on making this an important feature. Below you will find several new features. Links to information on our most current new ideas appear just below. One section lower you will find new features to the site: The "Heating Up" column where we cover Wall Street's coming focus, the "Technology Trends" column, where we look at mega changes in technology, and the "Market Wise" section, where we cover some tried and true strategies for making money in the markets. Below these new sections are links to the major news events effecting the market that day.
The Right Hand Column: The right hand column is very important on a daily basis. At the top you will find links to the most current BLOG Entries. Just below are links to the most current Full Editions. At the bottom you will find another new column: The Traders Corner where we share strategies for better trading practices and swing trading ideas in larger cap stocks we have identified.

I believe you will find the information on the new site much more comprehensive and accessible. For example, in the past if you wanted to find out the current price target and SSL for one of our followed companies, you had to dig into the archive section. Now the information is on a simple table on the left side of the home page. I felt it was important for investors to get that information easily and quickly to aid any buying and/or selling decisions.

I hope you like this new version of the OTC Journal. We plan to continue the improvements. Feedback and/or suggestions would be greatly appreciated. Please email editor@otcjournal.com.

Comments in the BLOG

There were lots of earnings releases last week from the companies in our little microcap world. Quarterly numbers are very meaningful to potential price performance for several of the companies, not so important to others. For example, Bad Toys came in with revenues about as expected north of $11 million for the quarter. Earnings were a bit weaker than hoped for, but they have been spending a lot on legal fees thanks to the S1 for the Southland spin off, and fighting their creditors. Since it was already priced into the stock, it wasn't too meaningful. MAIL came in with strong earnings and the stock responded with an impressive 2 day run, only to pull back. For biotechs KAL and ACTC, earnings are not too meaningful. Clinical trials and published results are all that matter.

I am really looking forward to getting some hard numbers from Titan Global- this one could be a rocket ship once hard numbers prove they are delivering. Lots going on there to suggest numbers will improve. Their fiscal year is quite bizarre- it was the end of August. Therefore, we will see audited numbers by the end of this month, and fiscal Q1 numbers (which should be impressive) by mid January. For Commerce Planet (CPNE)- clearly the most followed and traded OTC Journal idea, numbers are all that matter. Once investors are convinced the trend that has been established over the past 3 quarters will continue, there is no predicting how high the stock could go. My immediate target still remains $2.

A couple more earnings reports bear reviewing, but I will not get to them until after Thanksgiving week. I am publishing today's edition, one post close on Monday, and that will be it until after Thanksgiving week unless something major comes up.

The BLOG is your opportunity to ask questions and offer comments. I will make an effort to answer every legitimate question. If I don't know the answer, I will contact the management and get the answer. Alternatively, if you have questions you don't want publicly displayed, you can always email me directly at editor@otcjournal.com.

To use the BLOG, simply go to the home page at www.otcjournal.com - the BLOG will scroll down automatically on the right side of your screen. The most current journal entries appear in the middle of your screen. Check back frequently for updates particularly when stocks are moving to overbought or oversold levels in volatile markets.

Subscribe

Information is power and timely information is profitable. Become informed and profit from OTC Journal Profiles and Trading Alerts by becoming a Preferred Member today. There is no cost associated with your email subscription. Add your email address below and make sure to check your email inbox and confirm your opt-in request to start receiving the OTC Journal Email Newsletter on a regular basis.

To ensure newsletter delivery, you can add any additional email addresses you may have to the OTC Journal Member List. Receiving the OTC Journal Newsletter in multiple locations is the best way of making sure you don't miss the next investing or trading opportunity! For web based email addresses, the OTC Journal recommends @yahoo.com or @aol.com for timely and reliable email newsletter delivery.

Note: Your email address will be kept strictly confidential, and will not be shared with any other entity for any purpose at any time. If you no longer wish to receive the OTC Journal, simply follow the instructions located at the bottom of every OTC Journal Newsletter Edition.

Disclaimer

The OTCjournal.com Newsletter is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible. Moreover, as detailed below, this publication accepts compensation from certain of the companies which it features. Likewise, this newsletter is owned by MarketByte, LLC. To the degrees enumerated herein, this newsletter should not be regarded as an independent publication.

Go Here to view our compensation on every company we have ever covered, or visit the following web address: http://www.otcjournal.com/disclaimer.html for our full profiles and http://www.otcjournal.com/trading-alerts/disclaimer.html for Trading Alerts.

All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the newsletter is neither an offer nor solicitation to buy or sell any securities mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.

From time to time MarketByte LLC sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.

The editor, members of the editor's family, and/or entities with which they are affiliated aside from MarketBtye LLC itself, are forbidden by company policy to own, buy, sell or otherwise trade stock for their own benefit in the companies who appear in the publication unless specifically disclosed in the newsletter. Some of the companies featured in the OTC Journal pay a cash ESP fee to an affiliated technology company ranging from $2,000 to $5,000 per month for internet related technology services.

The Trustee of the MarketByte LLC Defined Benefit and Trust (“the MarketByte Pension Plan”) has invested approximately $140,0000 in Dutchess Private Equities II LP (“the Dutchess Limited Partnership”), a limited partnership in which the MarketByte Pension Plan is a limited partner. The Trustee of the MarketByte LLC Defined Benefit and Trust (“the MarketByte Pension Plan”) has invested approximately $190,0000 in the Longview Fund (“the Longview Limited Partnership”), both limited partnerships in which the MarketByte Pension Plan is a limited partner. No one associated with the MarketByte Pension Plan has any knowledge, information, or control as to any past, present, or future investment activities of the Dutchess Limited Partnership or the Longview Fund. The Dutchess Limited Partnership is one of two hedge funds managed by Dutchess Advisors. Dutchess Advisors and Longview periodically refers companies to MarketByte LLC for possible coverage by one of the MarketByte LLC publications, which publications include The OTCJournal.com Newsletter. Dutchess Advisors or Longview may or may not own shares in the companies that it so refers to MarketByte. MarketByte has no information (outside of information readily accessible to the general public such as SEC filings) as to whether Dutchess Advisors or Longview owns any shares in the companies that it refers to MarketByte LLC. The above relationships should be viewed as a potential and/or actual conflict of interest by shareholders and prospective shareholders of MarketByte LLC client companies.

The profiles, critiques, and other editorial content of the OTCjournal.com may contain statements that appear foward relating to the expected capabilities of the companies mentioned herein.

THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF OTCjournal.com.

We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at http://www.sec.govand/or the National Association of Securities Dealers ("NASD") at http://www.nasd.com. We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm. Disclaimer ID:$subst('Recip.userid') Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site. MarketByte LLC's mailing address is 4653 Carmel Mtn Rd Suite 308 #402, San Diego, CA 92130.

You can unsubscribe from this list at any time by Clicking Here. If you are having difficulty removing yourself or wish to change your address please go to http://www.otcjournal.com/opt.html?.